REDHILL BIOPHARMA LTD. (RDHL) Operating margin 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) operating margin by fiscal year — reported operating income divided by reported revenue.
-181.7%FY2024 · since FY2015: -733400.0% → -181.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -181.7% | -375.1 pp |
| FY2023 | 193.4% | +262.8 pp |
| FY2022 | -69.3% | +25.3 pp |
| FY2021 | -94.6% | +4.3 pp |
| FY2020 | -99.0% | +587.8 pp |
| FY2019 | -686.7% | -216.2 pp |
| FY2018 | -470.5% | +826.6 pp |
| FY2017 | -1297.0% | +28943.6 pp |
| FY2016 | -30240.6% | +703159.4 pp |
| FY2015 | -733400.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice